ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,225, issued on Dec. 9, was assigned to IDP DISCOVERY PHARMA S.L. (Barcelona, Spain).
"Melanocyte-regulating peptides" was invented by Laura Nevola (Barcelona, Spain) and Santiago Esteban Martin (Barcelona, Spain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The peptides of the invention have a sequence with at least 85% identity with a sequence SEQ ID NO: 1 or 2.These peptides regulate melanocyte activity in terms of proliferation and production of melanin. Therefore, they are useful in the treatment of melanomas but also of cosmetic cutaneous hyper or hypopigmentation."
The patent was filed on July 31, 2020, under Application No. 17/632,463.
*For...